Medtronic Launches Mobile App That Communicates Directly with World's First Smartphone-Connected Pacemakers
16 January 2019 - 2:00AM
MyCareLink
Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay
Connected with Their Clinics
DUBLIN - January 15, 2019 -
Medtronic plc (NYSE:MDT) today announced the launch of its
MyCareLink Heart(TM) mobile app to support the world's first and
only portfolio of pacemakers that can communicate directly with
patients' smartphones and tablets.
Compatible with Medtronic BlueSync(TM)
technology-enabled pacemakers, the MyCareLink Heart mobile app is
designed to securely and wirelessly send device data to the
Medtronic CareLink(TM) network via smart technology, eliminating
the need for a dedicated bedside monitor or other remote monitoring
hardware.
"For the first time, pacemakers have the ability
to communicate securely and directly with technology that patients
use every day like smartphones and tablets," said Aisha Barry, vice
president and general manager for the Connectivity & Insights
business, which is part of the Cardiac and Vascular Group at
Medtronic. "This brings the benefits of remote monitoring
seamlessly into patients' lives, potentially leading to enhanced
and more efficient patient engagement with their physicians."
BlueSync technology-enabled pacemakers include the
Azure(TM) pacemaker and Percepta(TM), Serena(TM) and Solara(TM)
quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps).
Data collected by these devices is encrypted and sent to the
CareLink network through the MyCareLink Heart mobile app, providing
physicians with timely alerts on clinically-relevant patient
events. The app also makes select pacemaker data easily accessible
to patients including transmission success history, pacemaker
battery information, answers to common questions about living with
a pacemaker, and updates on physical activity.
"The MyCareLink Heart mobile app is a
technological game-changer for people with pacemakers," said James
Allred, M.D., electrophysiologist at Cone Health Medical Group
Heartcare in Greensboro, N.C. "The introduction of convenient and
secure data transmissions and easy access to information like
pacemaker battery life changes how patients track and understand
their heart health."
Upgrades to the MyCareLink Heart Mobile app
technology will be available to patients' devices over the lifetime
of their BlueSync-enabled devices. Features currently include:
MyCareLink Heart Mobile App
Features:
-
Transmission History:
Provides patients with information about transmissions that have
been sent to their doctors, as well as confirmation when
transmissions are received by physicians.
-
Vitals Tracking: Allows
patients to record weight, blood pressure and heart rate in the
app, and to track these measurements over time to help better
understand health status. This information is only stored on their
mobile device; it is not sent to the clinic.
-
Battery Longevity: Displays
the estimated remaining battery life of patients' Medtronic heart
devices enabled with BlueSync technology.
-
Symptom Journal: Allows
patients to catalog symptomatic events which can be reviewed with
their physicians during in-person clinic visits. This information
is only stored on their mobile device; it is not sent to the
clinic.
-
Device Information:
Displays device implant date, heart device name, model number and
serial number - as well as patients' clinic information.
-
Education: Offers helpful
information and common questions about living with a
pacemaker.
-
Physical Activity: Provides
information about patients' activity levels. The app uses data from
patients' heart devices to create daily, weekly and monthly views
of physical activity.
In addition to building the MyCareLink Heart
mobile app to deliver unique benefits for patients and clinicians,
Medtronic prioritized high-level security design capabilities. The
security controls built into BlueSync technology-enabled heart
devices and the MyCareLink Heart mobile app include encryption and
access restrictions designed to protect the device and data
transmissions.
In collaboration with leading clinicians,
researchers and scientists worldwide, Medtronic offers the broadest
range of innovative medical technology for the interventional and
surgical treatment of cardiovascular disease and cardiac
arrhythmias. Medtronic strives to offer products and services of
the highest quality that deliver clinical and economic value to
healthcare consumers and providers around the world.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 86,000 people worldwide, serving physicians,
hospitals and patients in more than 150 countries. The company is
focused on collaborating with stakeholders around the world to take
healthcare Further, Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
The Bluetooth® word mark and
logos are registered trademarks owned by Bluetooth SIG, Inc.
Medtronic and the Medtronic logos are trademarks of Medtronic. All
other Medtronic products are trademarks of a Medtronic
company.
-end-
Contacts:
Ryan Mathre
Public Relations
+1-763-514-9625
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2024 to May 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From May 2023 to May 2024